Home / Blood Tests / ROMA-POST

ROMA-POST

What Is the ROMA Test?

The Risk of Ovarian Malignancy Algorithm (ROMA™) test is designed to help evaluate the likelihood of ovarian cancer in women presenting with a pelvic mass.

How the Test Works

The assessment is based on a combination of the patient’s HE4 and CA125 biomarker levels, along with their menopausal status.

There is an additional £20 phlebotomy fee for every donation.